G0472 HCPCS Level II code: Hepatitis c antibody screening, for individual at high risk and other covered indication(s)
G0472 is the HCPCS code for “Hepatitis c antibody screening, for individual at high risk and other covered indication(s)” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
G0472Hepatitis c antibody screening, for individual at high risk and other covered indication(s)
Short description: Hep c screen high risk/other
HCPCS · United States
Notes for G0472
As CMS prints them, with any note G0472 takes from the headings above it.
Note
- CMS processing note 0199: SEE CR 8871, SERVICE IS APPROVED PER NCD COVERAGE; RESTRICTIVE GUIDELINES.
Medicare details
The indicators CMS publishes with G0472 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Physician fee schedule – Price established by carriers (e.g., not otherwise classified, individual determination, carrier discretion); Clinical lab fee schedule – Price subject to national limitation amount
- Type of service
- Diagnostic laboratory
- BETOS category
- Ambulatory procedures - other
- Lab certification
- General immunology
- Coverage statute
- 1861SSA
- Added
- Jun 2, 2014
Where G0472 sits
- 1G codesProcedures and professional services
- 2Active code G0472Hepatitis c antibody screening, for individual at high risk and other covered indication(s)
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code G0472 mean?
G0472 is the HCPCS code for “Hepatitis c antibody screening, for individual at high risk and other covered indication(s)” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover G0472?
CMS lists G0472’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Physician fee schedule – Price established by carriers (e.g., not otherwise classified, individual determination, carrier discretion); Clinical lab fee schedule – Price subject to national limitation amount”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside G0472
All G codesG0466Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which…G0467Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc…G0468Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and…G0469Federally qualified health center (fqhc) visit, mental health, new patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between a new patient and a…G0470Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an…G0471Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health…G0473Face-to-face behavioral counseling for obesity, group (2-10), 30 minutesG0475Hiv antigen/antibody, combination assay, screeningG0476Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical…G0477Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) capable of being read by direct optical observation only (e.g.…G0478Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) read by instrument-assisted direct optical observation (e.g.…G0479Drug test(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, tof, maldi…